Autres langues Enanta Pharmaceuticals, Inc.

Actions

ENTA

US29251M1062

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/06/2024			Varia. 5j.	Varia. 1 janv.
12,78 ^USD	-1,01 %		+3,07 %	+35,60 %

07/05	ENANTA PHARMACEUTICALS, INC. : JMP Securities optimiste sur le dossier	ZM
06/05	Transcript : Enanta Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 06, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference	29/05
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference	07/05
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot	06/05
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Posts Q2 Revenue $17.1M, vs. Street Est of $16.2M	06/05
Enanta Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	06/05
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET	06/05
Enanta Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4)	01/05
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	30/04
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer	30/04
Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer	30/04
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024	29/04
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024	17/04
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference	06/03
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Reports Q1 Revenue $18M, vs. Street Est of $21.9M	07/02
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot	07/02
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET	07/02
Enanta Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	07/02
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023	31/01
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference	04/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Enanta Pharmaceuticals, Inc.

Actions

ENTA

US29251M1062

Autres langues

Filtres